SLC2A2 and type 2 diabetes mellitus: As reported previously, HFHSD raising was used to develop insulin resistance model [50, 51]; meanwhile, STZ enters the pancreatic β cell via a glucose transporter GLUT2 and induces a mild impairment of insulin secretion which is similar to the feature of the later stage of type 2 diabetes [23].